Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 3.5% in the afternoon session after the company reported third-quarter financial results that met, but did not ...

Abbott trades at half Lilly's valuation multiple, but Lilly's 45% revenue surge and 32% net margin raise the stakes for ...

Abbott Laboratories (ABT) delivered a strong Q2 2026 performance that surprised Wall Street, with the healthcare giant posting a double beat on both top and bottom lines on July 16, 2026. The earnings ...

Abbott Laboratories has shed billions in market value this year while the broader market climbed, yet one analyst on Wall ...

This was the stock's second consecutive day of gains. Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the ...

Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual ...

View Abbott Laboratories ABT stock quote prices, financial information, real-time forecasts, and company news from CNN.

June 28 (Reuters) - The U.S. Justice Department closed a criminal probe into Abbott Laboratories over its handling of a baby formula plant linked to potentially deadly bacteria and infant deaths, ...

Abbott Laboratories (NYSE:ABT) has greatly exceeded the broader S&P 500 index this year, with its stock price increasing by 18% compared to the S&P 500’s 6% rise. This strong performance is due to the ...

July 17 (Reuters) - Abbott Laboratories ⁠is ⁠investigating two cyber ⁠incidents involving unauthorized access to some ...

Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street Abbott Laboratories (NYSE:ABT) reported second-quarter 2026 comparable sales growth of 4.8% and adjusted earnings per share of $1.31, ...

Abbott trades at a cheaper valuation but carries higher litigation risk, while J&J boasts superior profitability despite a ...